Viewing Study NCT04813406


Ignite Creation Date: 2025-12-26 @ 2:40 PM
Ignite Modification Date: 2026-03-01 @ 1:50 AM
Study NCT ID: NCT04813406
Status: UNKNOWN
Last Update Posted: 2021-03-24
First Post: 2021-03-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Anlotinib Plus Sintilimab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
Sponsor: Henan Provincial People's Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module